{"name":"Eclipse Life Sciences, Inc.","slug":"eclipse-life-sciences-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxOZkpoOHZJTjRkbXVuWFhqZXVEMWM0b2pzaHQ3dTFZQWFQR3YxUVVzLU8ya2JEbEhKVjEtenMwb20xSDNfRE1tMTd0Qlg0bGROVmdyVURTQjM0STg3Q195aC1zVjJSbnFlR3FOd29PTm8ybGNGWGpkTFd0WERhek1scDEtc1JmUDdkVWxGendmd1Nnbklv?oc=5","date":"2026-03-12","type":"regulatory","source":"openPR.com","summary":"Diabetic Macular Edema Treatment Pipeline Shows Strong - openPR.com","headline":"Diabetic Macular Edema Treatment Pipeline Shows Strong","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxOaVlpQS1NTHBWa3VFQ0FlakE5NjVrUlVXdFdtRmZsdVEzZHhGYnFJdk5IeE41WERUbVk3cXpmYTRfcUNEcmFvNXpwYnhHbVFxZWxaaS1pdWVpNTNlSWlBRXZXYlIwZWJhWkQzV01VWGk4WGExc3VUZUItNkZBV0RrSldOVUpiYnZPR05qS0RvQXJOc3h5aGdxWHRsWl9OQW1SZnFvWEFpXzJwR0FSMlpN?oc=5","date":"2026-01-28","type":"pipeline","source":"Fierce Pharma","summary":"Cellares' series D round draws $257M as cell therapy contractor takes operations global - Fierce Pharma","headline":"Cellares' series D round draws $257M as cell therapy contractor takes operations global","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxNc3NsZGFfTDUyaUg0ejBIMHVjajFNVGRkdE92amNYTnlMWjdaYm5Zenh2azhJRXI0TC1HQS16V1E2b2llNjNXZ1NzVWRLb0FCM2s0RmtaR0xzaXJEUjVheGY4aXNTbmJoOG55SzE0Z0p1b0J3WGRDOXBFZmFrZmR0ZXRJMA?oc=5","date":"2026-01-26","type":"deal","source":"Contract Pharma","summary":"Eclipsebio Acquires Terrain Bio - Contract Pharma","headline":"Eclipsebio Acquires Terrain Bio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxQeXdJQkZVUGVzNGV1aWxOTTQwdnRYb21uZXY3c2o0eDdjMFVENmtmczJ3ZDA3R2QyaC1WTnNRamcwNERIMGl0emhab2tSdEtRc0xfQ1ZDV2lxWDAxS2hlYzIzekExbGItbVRpWFFURE14ME1jUGMxR3VsYzFjazdabFRuMURkSnBpSFpubVVuTEh4R1l0cy1NYVdGUk5QRnZ6Y2tSanc4TTFHLVVwclNCM01wNHU?oc=5","date":"2025-12-02","type":"pipeline","source":"Fierce Pharma","summary":"Pharmas have promised $370B in US investments amid 2025's onshoring boom: DPR - Fierce Pharma","headline":"Pharmas have promised $370B in US investments amid 2025's onshoring boom: DPR","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-09-07","type":"pipeline","source":"The Times of India","summary":"Navsari firm cheated of 2.17cr by Indore pharma company, 4 booked - The Times of India","headline":"Navsari firm cheated of 2.17cr by Indore pharma company, 4 booked","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxPU0h2OURla2dSRUJDbjI0d0pXVFQtRS1YWVZ6NmtiNmZrU2dfTjVaSUZxUmRNYUJzTWx4UGVCVk9od3pvSThjb3g1MFVkeGlWZHdvMktvVEJYc2x5QW04a3Raa3M2ZjVDVElFVmF6Zi1MQ0VidEMzZ29SaG03U29PQWx4SlhfV1Rt?oc=5","date":"2025-03-12","type":"pipeline","source":"charlotteobserver.com","summary":"Which NC organizations would be impacted by Trump’s NIH funding cuts? Here’s a list - charlotteobserver.com","headline":"Which NC organizations would be impacted by Trump’s NIH funding cuts? Here’s a list","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidEFVX3lxTE91UU1yeGVVc29MTzZBeWctWEFLZlJ0TVJTQ29kWENSNlA5dF9NTFhNdjJWRlRKOGdoRTE1YWdhMmdSREJmTzZvTFllVlNucVRfakxYQzZxakhSTHVnUHFnU3BmbEtlOENVQXpvWlZBYlV2Q0RS?oc=5","date":"2025-01-15","type":"pipeline","source":"BioSpace","summary":"2024’s Top 7 VC Raises in Biotech - BioSpace","headline":"2024’s Top 7 VC Raises in Biotech","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxPWklRM2M0V0lnMURyMGdDZGc3YjEydDN5dHZuVzJfSkJtcUhCTGxkNkRjZjNtbFlNdHY0b1lLcWRWcThiM0FLTm1JLTBMZWZCemRpZnNQYmE5UXAxdzBXckY4eEkzdGFhOUpOSnBBREtEY2F3UXIybFdyQVhDSWFqTk5oUXo2ZFlIcTliS3RCclhnMGNkOTh3bFVUNW1tOVFnSERqVzNqMWlIWXdHX0tpcjd2bXRDQW12bzB5ejB3d2lqNzhIcjVBaQ?oc=5","date":"2022-10-12","type":"pipeline","source":"Mayo Clinic News Network","summary":"Eclipse and Mayo Clinic create Nucleus RadioPharma to better serve cancer patients - Mayo Clinic News Network","headline":"Eclipse and Mayo Clinic create Nucleus RadioPharma to better serve cancer patients","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxQSWFmVGZqX1hjWnVZOXVuV3NMMzg3OUJsVl9UVTBnNUIxQnJjTEdzUzBHeEo3QmlFcTFHdEhLMjZFcmRmWnhGQ3RzZVQzVmFPM0FGNHlIUHBwY2ttLXEtZzItOXA5Q2tFVzdTT0l0UDhKMkk5aUppTUo1VUI3WWZCci10T2ZJVHYxWUxLVFI1bGMzTDNEWlp6QzY3Uy01OVRvT3JGX1RR?oc=5","date":"2022-03-15","type":"pipeline","source":"MedCity News","summary":"Biotech startup Eclipsebio emerges to shed light on RNA drug research - MedCity News","headline":"Biotech startup Eclipsebio emerges to shed light on RNA drug research","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxNNVFvV0dwRXQzTHZfU2oxcUcwZFl3aVhyQWNKWWl2Ti1vTkN5OTBuV3VGOFlUdFZvTWRJcHhzTFp0SEFZTnZPRmZ5X3EwMktDajhGVmt5c2I3aVFBUU5QeWhXRnUxb1RzZ0dMRlV6Mmc5VTZuT0hDQzhvQkszUUhJQVczVklIalB5YzB0Y0JyWFlYU0xCdWppMlI5THR3VjN5RzMwdTJEUGtSNDdoOGhnd0w3aUxzSDI2RV9MOERWTlF6Vnl5UHplWVByZFhjWGNJRDFiZXRiX09BSjZFN2hiakwta3plZXNxeEZsbA?oc=5","date":"2021-11-10","type":"pipeline","source":"Cerebras","summary":"Cerebras Systems Raises $250M in Funding for Over $4B Valuation to Advance the Future of Artificial Intelligence Compute - Cerebras","headline":"Cerebras Systems Raises $250M in Funding for Over $4B Valuation to Advance the Future of Artificial Intelligence Compute","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxPQWJSYVlBd2Y1ZEhJb1RVUFRiMkNOV2NzZThBMUE3YUNHbHVaZTZ3cUVXdDA2VmNrdlZaR3lGaUV3bllhOE5aWk5XSFZDMmpkLWlZbXZHVlBIRFhRVHBIT19MZmRoN0pfZmUwUGJnU3UyeHFMZGkyejJFSjNpREtjN29BSlpnQ1dvTDFiNmQwT0dvQQ?oc=5","date":"2021-09-23","type":"pipeline","source":"KKR: A Leading Global Investment Firm","summary":"KKR Invests in 400 Summer Street Joint Venture in Boston Seaport - KKR: A Leading Global Investment Firm","headline":"KKR Invests in 400 Summer Street Joint Venture in Boston Seaport - KKR: A Leading Global Investment Firm","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5AFBVV95cUxNXzU1OFp0TENfOVRFUGtIMWYySVZaa1BxTnItb3dZRFFuRmo5cF9jallVU09rLUZwOGE4SFNPbDlrOFB0YVVvVEZNUl8wd0hubTB1MWZlM2ctaHZCSTJnS3J1VnZZeG95dHoyWmgtcERwdUx0aTNyVkl4ZU0zRDBTRHRnMFdXakFiUVA2Qmd1ckJWTWZKQXlXb3N2Z1pWV1lfeC01X0hVMXZ4WWpaTC1QNVJDSlUyTTZrRm1mMHotRW1vS2lLZFNPaUdNemo5bDF0RENZYkVReWpENFhBT0J1blpzcUw?oc=5","date":"2020-09-24","type":"pipeline","source":"European Pharmaceutical Review","summary":"A ground-breaking BET platform for compliant, simplified endotoxin testing: Sievers Eclipse - European Pharmaceutical Review","headline":"A ground-breaking BET platform for compliant, simplified endotoxin testing: Sievers Eclipse","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}